CCL2 and inflammatory breast carcinoma: CCL2 mRNA was also highly upregulated in A3250 cells not only in comparison to SUM149, but also to IBC3 and to a panel of non-IBC breast cancer cell lines (Fig. 7c, Supplementary Table 4).